Testing violations of the exponential assumption in cancer clinical trials with survival endpoints
DOI10.1111/BIOM.12590zbMATH Open1372.62068OpenAlexW2524127088WikidataQ39350574 ScholiaQ39350574MaRDI QIDQ5283334FDOQ5283334
Authors: Gang Han, Michael J. Schell, Heping Zhang, Daniel Zelterman, Lajos Pusztai, Kerin Adelson, Christos Hatzis 
Publication date: 21 July 2017
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc6093291
Recommendations
- Optimality of testing procedures for survival data in the nonproportional hazards setting
- Adaptive designs for the one-sample log-rank test
- Exact tests for exponential regression
- Equivalence of two treatments and sample size determination under exponential survival model with censoring
- scientific article; zbMATH DE number 3960834
Applications of statistics to biology and medical sciences; meta analysis (62P10) Testing in survival analysis and censored data (62N03)
Cites Work
- Title not available (Why is that?)
- Recent and classical tests for exponentiality: a partial review with comparisons
- The Reduced Monotonic Regression Method
- Testing to Determine the Underlying Distribution Using Randomly Censored Data
- Chi-square goodness-of-fit test for randomly censored data
- Pearson-Type Goodness-of-Fit Tests: The Univariate Case
- Generalized Pearson-Fisher chi-square goodness-of-fit tests, with applications to models with life history data
- What Price Kaplan-Meier?
- Goodness-of-fit tests for randomly censored data
- The Price of Kaplan–Meier
- Small-Sample Properties of Censored-Data Rank Tests
Cited In (1)
This page was built for publication: Testing violations of the exponential assumption in cancer clinical trials with survival endpoints
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5283334)
